lobbying_filings_raw: cf66dd7b-4193-4c3b-aad9-e8ec94cfa540
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cf66dd7b-4193-4c3b-aad9-e8ec94cfa540 | Q2 | 316731 | DAIICHI SANKYO, INC. | 185884 | DAIICHI SANKYO INC | 2017 | second_quarter | 2017-07-18T23:39:05.707000-04:00 | 150000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/cf66dd7b-4193-4c3b-aad9-e8ec94cfa540/", "filing_uuid": "cf66dd7b-4193-4c3b-aad9-e8ec94cfa540", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2017, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/cf66dd7b-4193-4c3b-aad9-e8ec94cfa540/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "150000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Lance Gilgore", "dt_posted": "2017-07-18T23:39:05.707000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": "1825 K Street NW, Suite 425", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20006", "registrant": {"id": 316731, "url": "https://lda.senate.gov/api/v1/registrants/316731/", "house_registrant_id": 39286, "name": "DAIICHI SANKYO, INC.", "description": null, "address_1": "211 Mt Airy Rd", "address_2": null, "address_3": null, "address_4": null, "city": "Basking Ridge", "state": "NJ", "state_display": "New Jersey", "zip": "07920", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "AMANDA PEZALLA", "contact_telephone": "+1 202-223-6572", "dt_updated": "2026-01-23T12:14:15.149771-05:00"}, "client": {"id": 185884, "url": "https://lda.senate.gov/api/v1/clients/185884/", "client_id": 12, "name": "DAIICHI SANKYO INC", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-13"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Discussions regarding the Affordable Health Care Act (ACA)\nH.R.1703, Medical Product Communications Act of 2017", "foreign_entity_issues": "To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.", "lobbyists": [{"lobbyist": {"id": 6903, "prefix": null, "prefix_display": null, "first_name": "LANCE", "nickname": null, "middle_name": null, "last_name": "GILGORE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Discussions regarding Medicare", "foreign_entity_issues": "To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.", "lobbyists": [{"lobbyist": {"id": 6903, "prefix": null, "prefix_display": null, "first_name": "LANCE", "nickname": null, "middle_name": null, "last_name": "GILGORE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "H.R.2025, Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017\nH.R.2430 and S.934, FDA Reauthorization Act of 2017", "foreign_entity_issues": "To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.", "lobbyists": [{"lobbyist": {"id": 6903, "prefix": null, "prefix_display": null, "first_name": "LANCE", "nickname": null, "middle_name": null, "last_name": "GILGORE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |